NCT02103855View on ClinicalTrials.gov

Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Nephrotoxicity
Interventions
DRUG

Belatacept

Trial Locations (1)

46202

Indiana University Health, University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT02103855 - Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients | Biotech Hunter | Biotech Hunter